Pay in 4 interest-free payments of $32.73 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
gov/books/NBK548824/ PubMed PMID: 31644131
The expression of pFAK (Tyr397) is statistically significantly inhibited by Defactinib in a dose-dependent manner in all cell lines
the apoptotic cells are observed under the microscope and counted randomly at least 100 cells in one field
a novel hypoglycaemic agent
Kimlinger T
Indirubin 0156 gov/books/NBK548824/ PubMed PMID: 31644131Indirubin is a potent and selective CDK inhibitor. Indirubin is the active ingredient of Danggui Longhui Wan, a mixture of plants that is used in traditional Chinese medicine to treat chronic diseases. Indirubin has been used to treat the symptoms of leukemia. Further biological explorations revealed the ability of indirubin to bind cyclin dependent kinases and 6 bromoindirubin, extracted from mollusks, to bind glycogen synthase kinase 3. Studies have
US$ 5750.00
US$ 1250.00
US$ 4750.00
US$ 2250.00
US$ 1250.00